Fate Therapeutics Inc
Fate Therapeutics Inc (FATE) Option Chain
Read more
Tracking the FATE option chain helps you see every strike and expiry on Fate Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of FATE options activity at a glance. Use our scanner to monitor the FATE option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For FATE stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where FATE options are being actively traded, and where they are not.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 6.04 | 214 | 0 | 0.10 | 0.55 | 0.15 | 1.15 | 0.50 | -56.14 | — | 1.00 | 0.00 | 1.00 | 0 | 8 | 93.96 |
| 47.89 | 361 | 0 | 0.95 | 0.05 | — | 1.00 | 1.00 | -12.28 | — | 0.20 | 0.00 | 0.20 | 0 | 5 | 52.11 |
| 79.49 | 184 | 0 | 1.00 | 0.00 | — | 1.00 | 1.50 | +31.58 | 0.25 | 1.15 | 0.45 | 0.25 | 1 | 87 | 20.51 |
| 92.58 | 757 | 0 | 3.80 | 0.00 | — | 3.80 | 2.00 | +75.44 | 0.25 | 1.25 | 0.95 | -0.20 | 0 | 164 | 7.42 |
| 98.99 | 1,578 | 0 | 0.05 | 0.00 | — | 0.05 | 3.00 | +163.16 | 1.25 | 2.25 | 1.95 | -0.20 | 0 | 86 | 1.01 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank98.81% High
- Market cap (M$)139
- 52 weeks high-64.71%
- 52 weeks low20.00%
- Analyst recommendationBuy
2.09 - Target price$5.56
432.06% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-1.03
- EPS growth next 5 years0.59%
As of Nov 16, 2026